Rinus Wanders

3.9k total citations
53 papers, 2.8k citations indexed

About

Rinus Wanders is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Rinus Wanders has authored 53 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pulmonary and Respiratory Medicine, 20 papers in Radiology, Nuclear Medicine and Imaging and 18 papers in Oncology. Recurrent topics in Rinus Wanders's work include Lung Cancer Diagnosis and Treatment (33 papers), Lung Cancer Treatments and Mutations (20 papers) and Advanced Radiotherapy Techniques (18 papers). Rinus Wanders is often cited by papers focused on Lung Cancer Diagnosis and Treatment (33 papers), Lung Cancer Treatments and Mutations (20 papers) and Advanced Radiotherapy Techniques (18 papers). Rinus Wanders collaborates with scholars based in Netherlands, United States and Belgium. Rinus Wanders's co-authors include Philippe Lambin, Dirk De Ruysscher, Anne‐Marie C. Dingemans, Liesbeth Boersma, Cordula Pitz, Angela van Baardwijk, Gerben Bootsma, Bart Reymen, Wiel Geraedts and Dirk De Ruysscher and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Rinus Wanders

51 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rinus Wanders Netherlands	28	1.8k	1.3k	886	669	550	53	2.8k
Gabriella Macchia Italy	30	1.4k 0.8×	1.2k 1.0×	812 0.9×	1.0k 1.5×	1.2k 2.2×	318	3.6k
Chad G. Rusthoven United States	29	1.7k 0.9×	1.0k 0.8×	477 0.5×	417 0.6×	272 0.5×	104	2.4k
Alan Herschtal Australia	25	930 0.5×	732 0.6×	643 0.7×	477 0.7×	317 0.6×	80	2.0k
Abraham J. Wu United States	33	2.4k 1.3×	1.7k 1.3×	971 1.1×	839 1.3×	1.2k 2.2×	234	3.8k
Francesco Deodato Italy	26	1.2k 0.7×	836 0.7×	634 0.7×	933 1.4×	823 1.5×	230	2.5k
Janice Ryu United States	24	2.9k 1.6×	1.2k 1.0×	535 0.6×	940 1.4×	546 1.0×	42	3.7k
Shyam Kishore Shrivastava India	25	962 0.5×	512 0.4×	634 0.7×	982 1.5×	859 1.6×	138	2.6k
Teruki Teshima Japan	27	1.6k 0.9×	582 0.5×	874 1.0×	1.1k 1.6×	744 1.4×	200	2.9k
Devin Schellenberg Canada	20	1.0k 0.6×	1.0k 0.8×	522 0.6×	762 1.1×	452 0.8×	70	2.0k
Tiziana Comito Italy	27	1.1k 0.6×	830 0.7×	673 0.8×	961 1.4×	636 1.2×	96	2.4k

Countries citing papers authored by Rinus Wanders

Since Specialization

Citations

This map shows the geographic impact of Rinus Wanders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rinus Wanders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rinus Wanders more than expected).

Fields of papers citing papers by Rinus Wanders

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rinus Wanders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rinus Wanders. The network helps show where Rinus Wanders may publish in the future.

Co-authorship network of co-authors of Rinus Wanders

This figure shows the co-authorship network connecting the top 25 collaborators of Rinus Wanders. A scholar is included among the top collaborators of Rinus Wanders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rinus Wanders. Rinus Wanders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Loon, J. Van, Dirk De Ruysscher, Sophie Peeters, et al.. (2018). PV-0039: Outcome of elderly NSCLC patients treated with isotoxic RT dose-escalation using IMRT (NCT01166204). Radiotherapy and Oncology. 127. S15–S16. 1 indexed citations

Ruysscher, Dirk De, Rinus Wanders, Lizza Hendriks, et al.. (2018). Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450). Journal of Thoracic Oncology. 13(12). 1958–1961. 63 indexed citations

Reymen, Bart, Angela van Baardwijk, Rinus Wanders, et al.. (2014). Long-term survival of stage T4N0-1 and single station IIIA-N2 NSCLC patients treated with definitive chemo-radiotherapy using individualised isotoxic accelerated radiotherapy (INDAR). Radiotherapy and Oncology. 110(3). 482–487. 19 indexed citations

Oberije, Cary, Georgi Nalbantov, André Dekker, et al.. (2014). A prospective study comparing the predictions of doctors versus models for treatment outcome of lung cancer patients: A step toward individualized care and shared decision making. Radiotherapy and Oncology. 112(1). 37–43. 75 indexed citations

Zegers, Catharina M.L., Wouter van Elmpt, Roel Wierts, et al.. (2013). Hypoxia imaging with [18F]HX4 PET in NSCLC patients: Defining optimal imaging parameters. Radiotherapy and Oncology. 109(1). 58–64. 69 indexed citations

Ruysscher, Dirk De, J. Belderbos, Bart Reymen, et al.. (2012). State of the Art Radiation Therapy for Lung Cancer 2012: A Glimpse of the Future. Clinical Lung Cancer. 14(2). 89–95. 36 indexed citations

Baardwijk, Angela van, Wolfgang A. Tomé, Wouter van Elmpt, et al.. (2012). Is high-dose stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC) overkill? A systematic review. Radiotherapy and Oncology. 105(2). 145–149. 79 indexed citations

Reymen, Bart, Judith van Loon, Angela van Baardwijk, et al.. (2012). Total Gross Tumor Volume Is an Independent Prognostic Factor in Patients Treated With Selective Nodal Irradiation for Stage I to III Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 85(5). 1319–1324. 34 indexed citations

Steevens, Jessie, Dirk De Ruysscher, Anita A.M. Botterweck, et al.. (2011). Also elderly patients (75 years or older) with stage III non-small cell lung cancer (nsclc) have survival gains with radical treatment: a prospective population-based study. Journal of Thoracic Oncology. 6(6). 1 indexed citations

10.

Baardwijk, Angela van, Bart Reymen, Rinus Wanders, et al.. (2011). Results of a phase II trial on individualized radiation dose-escalation based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancer (NSCLC). Journal of Thoracic Oncology. 6(6).

11.

Ruysscher, Dirk De, Angela van Baardwijk, Jessie Steevens, et al.. (2011). Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: A prospective population-based study. Radiotherapy and Oncology. 102(2). 228–233. 39 indexed citations

12.

Péchoux, C. Le, A. Laplanche, Corinne Faivre‐Finn, et al.. (2010). Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01). Annals of Oncology. 22(5). 1154–1163. 130 indexed citations

13.

Loon, Judith van, Dirk De Ruysscher, Rinus Wanders, et al.. (2009). Selective Nodal Irradiation on Basis of 18FDG-PET Scans in Limited-Disease Small-Cell Lung Cancer: A Prospective Study. International Journal of Radiation Oncology*Biology*Physics. 77(2). 329–336. 111 indexed citations

14.

Baardwijk, Angela van, Bart Reymen, Rinus Wanders, et al.. (2009). Individualized radiation dose escalation for stage I-III non-small cell lung cancer (NSCLC) based on normal tissue constraints: mature results of a phase II trial. Journal of Thoracic Oncology. 4(9). 1 indexed citations

15.

Loon, Judith van, Janneke P.C. Grutters, Rinus Wanders, et al.. (2009). 18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: An economic evaluation. European Journal of Cancer. 46(1). 110–119. 36 indexed citations

16.

Loon, Judith van, Geert Bosmans, Rinus Wanders, et al.. (2008). 18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: A planning study. Radiotherapy and Oncology. 87(1). 49–54. 59 indexed citations

17.

Ruysscher, Dirk De, Anita A.M. Botterweck, Miranda J.M. Dirx, et al.. (2008). Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study. Annals of Oncology. 20(1). 98–102. 143 indexed citations

18.

Ruysscher, Dirk De, Rinus Wanders, Monique Hochstenbag, et al.. (2007). HI-CHART: A Phase I/II Study on the Feasibility of High-Dose Continuous Hyperfractionated Accelerated Radiotherapy in Patients With Inoperable Non–Small-Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 71(1). 132–138. 31 indexed citations

19.

Ruysscher, Dirk De, Johan Bussink, Patrick Rodrigus, et al.. (2007). Concurrent celecoxib versus placebo in patients with stage II–III non-small cell lung cancer: A randomised phase II trial. Radiotherapy and Oncology. 84(1). 23–25. 11 indexed citations

20.

Langendijk, Johannes A., Jos de Jong, Rinus Wanders, Philippe Lambin, & Ben J. Slotman. (2003). The importance of pre-treatment haemoglobin level in inoperablenon-small cell lung carcinoma treated with radical radiotherapy. Radiotherapy and Oncology. 67(3). 321–325. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact